國立高雄大學圖資館 |

Language: English

Back

Novel therapeutic approaches for gas...

Nagaraju, Ganji Purnachandra.

Novel therapeutic approaches for gastrointestinal malignancies

Record Type:	Electronic resources : Monograph/item
Title/Author:	Novel therapeutic approaches for gastrointestinal malignanciesedited by Ganji Purnachandra Nagaraju, Sujatha Peela.
other author:	Nagaraju, Ganji Purnachandra.
Published:	Singapore :Springer Singapore :2020.
Description:	xii, 259 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Gastrointestinal systemCancer
Online resource:	https://doi.org/10.1007/978-981-15-5471-1
ISBN:	9789811554711$q(electronic bk.)

Novel therapeutic approaches for gastrointestinal malignancies
Novel therapeutic approaches for gastrointestinal malignancies[electronic resource] /edited by Ganji Purnachandra Nagaraju, Sujatha Peela. - Singapore :Springer Singapore :2020. - xii, 259 p. :ill. (some col.), digital ;24 cm. - Diagnostics and therapeutic advances in GI malignancies,2662-2688. - Diagnostics and therapeutic advances in GI malignancies..

Chapter 1. Role of selected transcription factors in pancreatic and colorectal cancer growth and metastasis -- Chapter 2. Adiponectin in gastrointestinal malignancies -- Chapter 3. Small molecule-targeted therapies for GI cancers: success and failures -- Chapter 4. Epigenetic biomarkers for the detection of Gastrointestinal Cancers -- Chapter 5. CD151: A Lateral organizer and modulator of Tumor microenvironment in gastrointestinal cancers -- Chapter 6. Targeting Pathways in GI Malignancies -- Chapter 7. Identification of Potential Key Genes Involved In Progression of Gastric Cancer Using Bioinformatics Analysis -- Chapter 8. Recent Development in the biomarkers for the gastric cancer -- Chapter 9. Gastric Cancer and it's remedy -- Chapter 10. An intergenic variant rs4779584 between SCG5 and GREM1 contributes to the increased risk of colorectal cancer: A meta-analysis -- Chapter 11. Phytochemicals plus nanomaterial's on colorectal cancer -- Chapter 12. Pancreatic Ductal Adenocarcinoma and Type 2 Diabetes Mellitus: Distant Relatives or the Close Ones? -- Chapter 13. Tumor Biomarkers and Diagnosis of Pancreatic Adenocarcinoma -- Chapter 14. Immunotherapy in Gastrointestinal Malignancies -- Chapter 15. The Role of HIF-1a in Hepatocellular Carcinoma.

This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses the latest trends in the use of small-molecule targeted therapies and immunotherapies as single agents or combination with other treatments. Since resistance to radiation and chemotherapy contribute to the high recurrence and poor survival rates, improving the outcome for GI malignancies is dependent on the introduction of new biomarkers and therapeutic agents. Lastly, the book systematically investigates novel theranostics approaches using nanotechnology for the detection, diagnosis, and personalized treatment of GI malignancies.

ISBN: 9789811554711$q(electronic bk.)

Standard No.: 10.1007/978-981-15-5471-1doiSubjects--Topical Terms:

651126
Gastrointestinal system
--Cancer

LC Class. No.: RC280.D5

Dewey Class. No.: 616.99433

Novel therapeutic approaches for gastrointestinal malignancies
LDR:03226nmm a2200337 a 4500 001 585799
003 DE-He213
005 20201230154842.0
006 m d
007 cr nn 008maaau
008 210323s2020 si s 0 eng d
020 $a 9789811554711$q(electronic bk.)
020 $a 9789811554704$q(paper)
024 7 $a 10.1007/978-981-15-5471-1 $2 doi
035 $a 978-981-15-5471-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.D5
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99433 $2 23
090 $a RC280.D5 $b N937 2020
245 0 0 $a Novel therapeutic approaches for gastrointestinal malignancies $h [electronic resource] / $c edited by Ganji Purnachandra Nagaraju, Sujatha Peela.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a xii, 259 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Diagnostics and therapeutic advances in GI malignancies, $x 2662-2688
505 0 $a Chapter 1. Role of selected transcription factors in pancreatic and colorectal cancer growth and metastasis -- Chapter 2. Adiponectin in gastrointestinal malignancies -- Chapter 3. Small molecule-targeted therapies for GI cancers: success and failures -- Chapter 4. Epigenetic biomarkers for the detection of Gastrointestinal Cancers -- Chapter 5. CD151: A Lateral organizer and modulator of Tumor microenvironment in gastrointestinal cancers -- Chapter 6. Targeting Pathways in GI Malignancies -- Chapter 7. Identification of Potential Key Genes Involved In Progression of Gastric Cancer Using Bioinformatics Analysis -- Chapter 8. Recent Development in the biomarkers for the gastric cancer -- Chapter 9. Gastric Cancer and it's remedy -- Chapter 10. An intergenic variant rs4779584 between SCG5 and GREM1 contributes to the increased risk of colorectal cancer: A meta-analysis -- Chapter 11. Phytochemicals plus nanomaterial's on colorectal cancer -- Chapter 12. Pancreatic Ductal Adenocarcinoma and Type 2 Diabetes Mellitus: Distant Relatives or the Close Ones? -- Chapter 13. Tumor Biomarkers and Diagnosis of Pancreatic Adenocarcinoma -- Chapter 14. Immunotherapy in Gastrointestinal Malignancies -- Chapter 15. The Role of HIF-1a in Hepatocellular Carcinoma.
520 $a This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses the latest trends in the use of small-molecule targeted therapies and immunotherapies as single agents or combination with other treatments. Since resistance to radiation and chemotherapy contribute to the high recurrence and poor survival rates, improving the outcome for GI malignancies is dependent on the introduction of new biomarkers and therapeutic agents. Lastly, the book systematically investigates novel theranostics approaches using nanotechnology for the detection, diagnosis, and personalized treatment of GI malignancies.
650 0 $a Gastrointestinal system $x Cancer $x Treatment. $3 651126
650 0 $a Gastrointestinal system $x Cancer $x Diagnosis. $3 458618
650 0 $a Gastrointestinal system $x Cancer $x Prevention. $3 877027
650 0 $a Cancer $x Research. $3 341951
650 0 $a Nanotechnology. $3 193873
650 0 $a Radiology. $3 188995
650 0 $a Gene expression. $3 188888
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Diagnostic Radiology. $3 274090
650 2 4 $a Gene Expression. $3 220379
700 1 $a Nagaraju, Ganji Purnachandra. $3 798639
700 1 $a Peela, Sujatha. $3 877026
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Diagnostics and therapeutic advances in GI malignancies. $3 859285
856 4 0 $u https://doi.org/10.1007/978-981-15-5471-1
950 $a Biomedical and Life Sciences (SpringerNature-11642)